Harvard Bioscience Inc
NASDAQ:HBIO

Watchlist Manager
Harvard Bioscience Inc Logo
Harvard Bioscience Inc
NASDAQ:HBIO
Watchlist
Price: 0.7535 USD -1.79% Market Closed
Market Cap: 33.6m USD

Intrinsic Value

The intrinsic value of one HBIO stock under the Base Case scenario is 2.5532 USD. Compared to the current market price of 0.7535 USD, Harvard Bioscience Inc is Undervalued by 70%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

HBIO Intrinsic Value
2.5532 USD
Undervaluation 70%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Harvard Bioscience Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about HBIO?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is HBIO valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Harvard Bioscience Inc.

Explain Valuation
Compare HBIO to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about HBIO?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Harvard Bioscience Inc

Current Assets 43.8m
Cash & Short-Term Investments 6.8m
Receivables 12.1m
Other Current Assets 24.9m
Non-Current Assets 34.2m
PP&E 12.5m
Intangibles 17.9m
Other Non-Current Assets 3.8m
Current Liabilities 54.4m
Accounts Payable 5.2m
Accrued Liabilities 10.8m
Other Current Liabilities 38.4m
Non-Current Liabilities 9.5m
Other Non-Current Liabilities 9.5m
Efficiency

Free Cash Flow Analysis
Harvard Bioscience Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Harvard Bioscience Inc

Revenue
87.4m USD
Cost of Revenue
-37.6m USD
Gross Profit
49.7m USD
Operating Expenses
-51.7m USD
Operating Income
-1.9m USD
Other Expenses
-51.9m USD
Net Income
-53.8m USD
Fundamental Scores

HBIO Profitability Score
Profitability Due Diligence

Harvard Bioscience Inc's profitability score is 29/100. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Strong 3Y Average Gross Margin
ROIC is Increasing
Operating Margin is Increasing
29/100
Profitability
Score

Harvard Bioscience Inc's profitability score is 29/100. The higher the profitability score, the more profitable the company is.

HBIO Solvency Score
Solvency Due Diligence

Harvard Bioscience Inc's solvency score is 34/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Low Altman Z-Score
34/100
Solvency
Score

Harvard Bioscience Inc's solvency score is 34/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

HBIO Price Targets Summary
Harvard Bioscience Inc

Wall Street analysts forecast HBIO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for HBIO is 2.04 USD with a low forecast of 2.02 USD and a high forecast of 2.1 USD.

Lowest
Price Target
2.02 USD
168% Upside
Average
Price Target
2.04 USD
171% Upside
Highest
Price Target
2.1 USD
179% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Harvard Bioscience Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for HBIO is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

HBIO Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one HBIO stock?

The intrinsic value of one HBIO stock under the Base Case scenario is 2.5532 USD.

Is HBIO stock undervalued or overvalued?

Compared to the current market price of 0.7535 USD, Harvard Bioscience Inc is Undervalued by 70%.

Back to Top